Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

A letter from several Democratic Senators urged Trump to use his deal-making skills to “flat out reject any request to end ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...

Novo sells semaglutide as Ozempic, Rybelsus and Wegovy. The CMS will treat the different forms as a single product in price ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Eli Lilly & Co.’s competing Mounjaro and Zepbound won’t be ... by law to continue the negotiation process on a tight ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

Medicare’s $35 insulin price cap was signed ... In 2023, insulin manufacturer Eli Lilly voluntarily capped out-of-pocket costs for its insulin at $35 at participating pharmacies for people ...